Intertek has announced that its cosmetics safety testing and regulatory experts will present at the Making Cosmetics Exhibition and Conference" March 25 – 26, 2014, at the Ricoh Arena, Coventry, UK.
Ashleigh Wake, Intertek’s biotechnology program manager - Intertek Healthcare and Beauty Products Group, will deliver a presentation on ‘Developing a strategy for in vitro sensitization alternatives to animal testing’ during the seminar session on 26 March at 09:55.
"The implementation of effective in vitro methods for assisting the development of novel cosmetics products is important. The challenge lies in strategically applying methods such as direct peptide reactivity assays to ensure robust and reliable data which can allow risk assessments to be made,” stated Ashleigh Wake.
Robert Fellous, Intertek’s business manager for Healthcare & Beauty Products says: “Following the ban on the sale of cosmetics developed through testing on animals in the EU in March 2013, healthcare and beauty product companies have a need for alternative methodologies to ensure their products are safe and effective. Intertek’s experts are committed to continuously and actively develop and introduce alternative methods to support these clients.”
Intertek experts in Regulatory, Analytical and Clinical Research Services will be present at the Intertek stand (Booth 123) to meet with clients throughout the event to discuss current industry issues and technical solutions.
